Durable Anti-SARS-CoV-2 Antibody Response after mRNA-1273 Booster in Peritoneal Dialysis Patients during the Omicron Wave.

Beilhack, Georg; Monteforte, Rossella; Frommlet, Florian; Reindl-Schwaighofer, Roman; Strassl, Robert; Vychytil, Andreas

Beilhack, Georg; Monteforte, Rossella; Frommlet, Florian; Reindl-Schwaighofer, Roman; Strassl, Robert; Vychytil, Andreas.

Afiliação

Beilhack G; Division of Nephrology and Dialysis, Department of Medicine III, Medical University of Vienna, 1090 Vienna, Austria.
Monteforte R; Division of Nephrology and Dialysis, Department of Medicine III, Medical University of Vienna, 1090 Vienna, Austria.
Frommlet F; Center for Medical Statistics, Informatics and Intelligent Systems, Medical University of Vienna, 1090 Vienna, Austria.
Reindl-Schwaighofer R; Division of Nephrology and Dialysis, Department of Medicine III, Medical University of Vienna, 1090 Vienna, Austria.
Strassl R; Division of Clinical Virology, Medical University of Vienna, 1090 Vienna, Austria.
Vychytil A; Division of Nephrology and Dialysis, Department of Medicine III, Medical University of Vienna, 1090 Vienna, Austria.

Vaccines (Basel) ; 11(6)2023 Jun 19.

Article em En | MEDLINE | ID: mdl-37376510

Palavras-chave

COVID-19; SARS-CoV-2; antibody response; mRNA-1273 vaccine; peritoneal dialysis

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Vaccines (Basel) Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Áustria

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google